Plasma-derived therapies are becoming increasingly important across immunology, hematology, neurology, transplantation, and critical care. Rising diagnosis of immune and bleeding disorders is supporting sustained treatment demand. The Blood Plasma Market was valued at US$44.83 billion in 2025 and is projected to reach US$83.02 billion by 2034, expanding at a CAGR of 8.01% from 2026 to 2034....